In the rest 310 renal transplant biopsies obtained from 203 kidney transplant recipients, there were 167 of type 6 (54%) including ATI; calcineurin inhibitor (CNI) toxicity; BK virus infection; recurrent diseases, 45 of type 3 (15%), 38 of type 1 (12%), 27 of type 2 (9%) including 12 acute antibody-mediated rejection (AbMR) and 15 chronic active AbMR, 26 of type 4 (8%) with 12 acute cellular rejection (ACR) type IA; 12 ACR type IB; 1 type IIA and 1 type IIB, and 7 of type 5 (2%).